Hyrimoz EC approval : Novartis biosimilar of AbbVie Humira approved in EU
Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe
Continue readingCoverage of Global Pharma Industry News
Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe
Continue readingUpdate on Imfinzi EMA approval : The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency
Continue readingCambrex has agreed to acquire Halo Pharma, a US CDMO (contract development and manufacturing organization), for $425 million to foray
Continue readingTibsovo (ivosidenib) developed by Agios Pharmaceuticals has been approved by the US Food and Drug Administration (FDA) for acute myeloid
Continue readingNivestym FDA approval : Pfizer has bagged approval from the US Food and Drug Administration (FDA) for Nivestym (filgrastim-aafi) –
Continue readingDutch pharma company Norgine has opened new offices in its largest product sales market – Germany at Wettenberg as part
Continue readingIvosidenib FDA approval : The US Food and Drug Administration (FDA) has approved Agios Pharmaceuticals’ blood cancer drug TIBSOVO (ivosidenib)
Continue readingNovartis has agreed to acquire the exclusive global development and marketing rights of atopic dermatitis drug MOR106 from MorphoSys and
Continue readingVyriad, a US biotech company, has entered into a collaboration with Germany-based Merck to launch a phase 1 trial of
Continue readingAn advisory committee of the United States Food and Drug Administration (FDA) has endorsed GSK malaria drug tafenoquine to be
Continue reading